To see the other types of publications on this topic, follow the link: Ovary.

Journal articles on the topic 'Ovary'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Ovary.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Corbett, Andrea L., Pam G. Krannitz, and Lonnie W. Aarssen. "The influence of petals on reproductive success in the arctic poppy (Papaver radicatum)." Canadian Journal of Botany 70, no. 1 (January 1, 1992): 200–204. http://dx.doi.org/10.1139/b92-027.

Full text
Abstract:
The flowers of the arctic poppy (Papaver radicatum L.) track the sun, and the petals of the flowers reflect light towards the ovary. This study investigated the importance of petals to reproductive success in this species. We measured light intensity, ovary temperature, seed weight, and number of seeds produced by flowers that had their petals removed versus flowers with their petals intact. Flowers without petals do not track the sun. Irradiance was greater when the photocell was held coincident with the angle of sun-tracking flowers than when facing upward. Flowers with petals had significantly higher overy temperatures both at the ovary surface and in the ovary interior than did flowers lacking petals. In pairs of flowers on the same individual plant, those with their petals removed had significantly fewer and smaller seeds than control flowers with petals intact. There were site differences in the significance of the treatment effect, but not in the magnitude of the differences between flowers with and without petals. Therefore, the presence of petals resulted in increased irradiance and temperature at and in the ovary, which affected reproductive success. Key words: heliotropism, Papaver radicatum, petals, reproductive success, temperature.
APA, Harvard, Vancouver, ISO, and other styles
2

Murmu, Dr Dasharatha, Dr Subrat Kumar Soren, Dr Kanumury Vandana, and Dr Ananta Satyanarayana M. "Fibroma of the Ovary." International Journal of Scientific Research 3, no. 4 (June 1, 2012): 351–52. http://dx.doi.org/10.15373/22778179/apr2014/124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Occhipinti, Kathryn A., Steven D. Frankel, and Hedvig Hricak. "THE OVARY." Radiologic Clinics of North America 31, no. 5 (September 1993): 1115–32. http://dx.doi.org/10.1016/s0033-8389(22)00359-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tripathi, Reva. "The ovary." Indian Journal of Medical Research 150, no. 3 (2019): 313. http://dx.doi.org/10.4103/ijmr.ijmr_1052_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schultze, Henrik, and Claus Fenger. "Accessory Ovary." Acta Obstetricia et Gynecologica Scandinavica 65, no. 5 (January 1986): 503–4. http://dx.doi.org/10.3109/00016348609157394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hall, Janet. "The Ovary." Endocrinologist 4, no. 5 (September 1994): 400. http://dx.doi.org/10.1097/00019616-199409000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Oktem, Ozgur, and Kutluk Oktay. "The Ovary." Annals of the New York Academy of Sciences 1127, no. 1 (April 2008): 1–9. http://dx.doi.org/10.1196/annals.1434.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "The Ovary." International Journal of Gynecological Pathology 14, no. 1 (January 1995): 94. http://dx.doi.org/10.1097/00004347-199501000-00018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cheung, Vincent Y. T. "Accessory Ovary." Journal of Obstetrics and Gynaecology Canada 32, no. 2 (February 2010): 107. http://dx.doi.org/10.1016/s1701-2163(16)34420-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mahmoud, M. S. "Maldescended Ovary." Journal of Minimally Invasive Gynecology 20, no. 6 (November 2013): S100. http://dx.doi.org/10.1016/j.jmig.2013.08.331.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Oransky, Ivan. "Zoltan Ovary." Lancet 366, no. 9483 (July 2005): 364. http://dx.doi.org/10.1016/s0140-6736(05)67013-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Findlay, J. K. "The ovary." Baillière's Clinical Endocrinology and Metabolism 5, no. 4 (December 1991): 755–69. http://dx.doi.org/10.1016/s0950-351x(10)80013-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Andersen, Richard N. "The ovary." Trends in Endocrinology & Metabolism 5, no. 9 (November 1994): 391. http://dx.doi.org/10.1016/1043-2760(94)90109-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Hart, R., and A. Magos. "The Ovary." Surgical Innovation 4, no. 4 (December 1, 1997): 210–18. http://dx.doi.org/10.1177/155335069700400404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

MMed(OandG), David G. Allen. "The Retained Ovary and the Residual Ovary Syndrome." Australian and New Zealand Journal of Obstetrics and Gynaecology 38, no. 4 (November 1998): 446–47. http://dx.doi.org/10.1111/j.1479-828x.1998.tb03108.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Rosenfield, Robert L. "The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum." Journal of Pediatric and Adolescent Gynecology 28, no. 6 (December 2015): 412–19. http://dx.doi.org/10.1016/j.jpag.2014.07.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Dumesic, Daniel A., and JoAnne S. Richards. "Ontogeny of the ovary in polycystic ovary syndrome." Fertility and Sterility 100, no. 1 (July 2013): 23–38. http://dx.doi.org/10.1016/j.fertnstert.2013.02.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Dr S.Krishnadas, Dr P. Lekshmi Ammal,. "Hyperinsulinemia in Polycystic Ovary Syndrome." Journal of Medical Science And clinical Research 05, no. 05 (May 6, 2017): 21286–95. http://dx.doi.org/10.18535/jmscr/v5i5.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

A, Bajaj. "The Neoplastic Nonage-Dysgerminoma Ovary." Open Access Journal of Gynecology 7, no. 3 (July 18, 2022): 1–3. http://dx.doi.org/10.23880/oajg-16000238.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Hismayasari, I., S. Rahayu, and A. Marhendra. "Ovary maturation stages histology and follicles diameter of Melanotaenia boesemani rainbowfish ovary from district of North Ayamaru, Maybrat Regency, west Papua." Journal of Morphological Sciences 32, no. 03 (July 2015): 157–64. http://dx.doi.org/10.4322/jms.082914.

Full text
Abstract:
Abstract Introduction: This research aim is to described ovary maturation stages histologically related with oocytes development in ovary of boesemani rainbowfish M. boesemani from North Ayamaru district, Maybrat Regency, West Papua. Materials and Methods: A histologycal analysis of ovari maturation stage (OMS) of the Boesemani rainbowfish Melanotaenia boesemani performed on 93 ovaries. Fresh ovaries were fixed in 10% Neutral Buffered Formalin (NBF) and embedded in paraffin. Section of about 5-6 pm thickness were cut and stained with Hematoxylin eosin (HE). Results: Histologycal analysis of rainbowfish M. boesemani ovaries based on oocyte development consist of 8 oocyte types not included atresia follicle i.e oogonia, early perinuclear oocyte, late perinuclear oocyte, cortical alveoli oocyte, early vitelogenic oocyte, mid-vitelogenic oocyte, late vitelogenic oocyte, and mature oocyte. The chorion and follicle layers begins to form at OMS II, keeps growing at OMS III, and was apparent at OMS IV. The chorion and follicle layers at OMS V ovaries were disintegrated. Conclusion: Based on ovary histology, oocyte proportion, and follicles diameter distribution can be concluded that the rainbowish M. boesemani classiied as multiple spawner.
APA, Harvard, Vancouver, ISO, and other styles
21

Diao, FY, M. Xu, Y. Hu, J. Li, Z. Xu, M. Lin, L. Wang, et al. "The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray." Journal of Molecular Endocrinology 33, no. 1 (August 1, 2004): 59–72. http://dx.doi.org/10.1677/jme.0.0330059.

Full text
Abstract:
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders; it is characterized by polycystic ovaries, hyperandrogenism and chronic anovulation. To obtain a global view of those genes that might be involved in the development of this complex clinical disorder, we used recently developed cDNA microarray technology to compare differential gene expressions between normal human ovary and ovaries from PCOS patients. A total of 9216 clones randomly selected from a commercial human ovary cDNA library were screened. Among them, 290 clones showed differential expressions, including 119 known genes and 100 known or unknown expressed sequence tags (ESTs). Among 119 known genes, 88 were upregulated and 31 downregulated in the PCOS ovary, as compared with normal human ovary. These differentially expressed genes are involved in various biologic functions, such as cell division/apoptosis, regulation of gene expression and metabolism, reflecting the complexity of clinical manifestations of PCOS. The molecular characteristics established from our study will further our understanding of the pathogenesis of PCOS and help us to identify new targets for further studies and for the development of new therapeutic interventions.
APA, Harvard, Vancouver, ISO, and other styles
22

HIRAI, MASANAO. "Ovary steroidogenesis abnormality and ovary dysfunction due to indomethacin." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 18, no. 1 (1987): 79–80. http://dx.doi.org/10.3999/jscpt.18.79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Erdem, C. Zuhal, Ulku Bayar, L. Oktay Erdem, Aykut Barut, Sadi Gundogdu, and Erdal Kaya. "Polycystic ovary syndrome: dynamic contrast-enhanced ovary MR imaging." European Journal of Radiology 51, no. 1 (July 2004): 48–53. http://dx.doi.org/10.1016/j.ejrad.2003.08.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Paliwal, Mohini, Vandana Bharti, and Kirti Tiwari. "Psychological Implication of Polycystic Ovary Syndrome." International Journal of Food, Nutrition and Dietetics 4, no. 3 (2016): 145–48. http://dx.doi.org/10.21088/ijfnd.2322.0775.4316.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Wikiera, Beata, Agnieszka Zubkiewicz-Kucharska, Julita Nocoń-Bohusz, and Anna Noczyńska. "Metabolic disorders in polycystic ovary syndrome." Pediatric Endocrinology Diabetes and Metabolism 23, no. 4 (2017): 204–8. http://dx.doi.org/10.18544/pedm-23.04.0094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Bajaj, Anubha. "The Flagellate Transition- Serous Carcinoma Ovary." Women's Health Science Journal 6, no. 1 (2022): 1–4. http://dx.doi.org/10.23880/whsj-16000166.

Full text
Abstract:
Serous ovarian tumours are engendered from Mullerian epithelium and denominate a segment of surface epithelial-stromal ovarian tumours. Serous ovarian carcinoma is classified as low grade tumefaction comprising of benign, borderline and low grade malignant lesions and high grade neoplasms. Staging of serous carcinoma of ovary is appropriately achieved with American Joint Committee on Cancer (AJCC), International Federation of Obstetrics and Gynaecology (FIGO) and Tumour, Node, Metastasis(TNM) staging. Surgical resection is an optimal and curative mode of therapy.
APA, Harvard, Vancouver, ISO, and other styles
27

Ganesh, Karuna, Ronak Shah, Efsevia Vakiani, Nancy E. Kemeny, Anne Lincoln, Christina Tran, Anna M. Varghese, et al. "Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC)." Journal of Clinical Oncology 34, no. 4_suppl (February 1, 2016): 564. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.564.

Full text
Abstract:
564 Background: Ovary mets constitute 5-10% of CRC mets, are associated with poor prognosis, cause morbidity due to disproportionately rapid growth compared with other mets and are less responsive to chemotherapy. The optimal management of ovary mets and the molecular basis of their unique growth pattern is unknown. Methods: 505 MSKCC patients with CRC (ICD-9 153, 154) and ovary mets (ICD-9 198.6) were identified. Patients without available pathology, with appendix cancer or only serosal ovary mets were excluded. Regression models were used to identify predictors of progression-free survival (PFS) and overall survival (OS) after surgery. Targeted exome sequencing of 341 cancer-associated genes was performed on 34 CRC ovary mets, including 20 matched pairs or trios of primary tumors, ovary mets and other mets from the same patient. Results: 184 patients with surgically resected CRC ovary mets were evaluated (median age 50 (17-86); OS 40 months (0.8-218) from CRC diagnosis, 23 months (0.2-199) from oophorectomy). 93/116 (80.2%) evaluable patients had concurrent growth of ovary mets on chemotherapy but shrinkage of other mets. In multivariate analysis, optimal surgical debulking was associated with improved PFS (HR = 0.11 (0.04-0.36)) and OS (HR = 0.42 (0.28-0.63)). Discordant ovary therapy response was associated with early progression (HR = 20.8 (1.59-274), and post-oophorectomy chemotherapy with reduced mortality (HR = 0.53 (0.33-0.84)). Ovary mets had increased KRAS (61.7% vs. 45.2%, p= 0.05) and SMAD4 (29.4% vs. 15.5%, p= 0.04) mutations compared to a 453 CRC cohort without ovary mets. In matched trios, mutations were largely concordant across tumor sites and no recurrent ovary met-specific mutations were found. However, 3/14 cases had identical mutations in the ovary mets and primary tumors, but additional private mutations in other mets. Conclusions: CRC ovary mets have frequent KRAS and SMAD4 mutations. Matched trios show clonal similarities between primary tumors and ovary mets, and divergence from other mets. Complete surgical resection of ovary mets is associated with substantially improved PFS and OS, similar to outcomes for localized CRC.
APA, Harvard, Vancouver, ISO, and other styles
28

Onciu, Teodora, and Remus Şipoş. "Polycystic ovary syndrome." Medic.ro 3, no. 135 (2020): 44. http://dx.doi.org/10.26416/med.135.3.2020.3239.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Burt Solorzano, Christine M., and Christopher R. McCartney. "Polycystic Ovary Syndrome." Endocrinology and Metabolism Clinics of North America 50, no. 1 (March 2021): 25–42. http://dx.doi.org/10.1016/j.ecl.2020.10.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Onciu, Teodora, and Remus Şipoş. "Polycystic ovary syndrome." Medic.ro 3, no. 135 (2020): 44. http://dx.doi.org/10.26416/med.135.3.2020.3239.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Aherne, S. Aisling. "Polycystic ovary syndrome." Nursing Standard 18, no. 26 (March 10, 2004): 40–44. http://dx.doi.org/10.7748/ns2004.03.18.26.40.c3565.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ji, Yong-Il, and Min Jeong Kim. "Polycystic Ovary Syndrome." Kosin Medical Journal 30, no. 2 (2015): 109. http://dx.doi.org/10.7180/kmj.2015.2.30.109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Ji, Yong-Il, and Min Jeong Kim. "Polycystic Ovary Syndrome." Kosin Medical Journal 30, no. 2 (2015): 109. http://dx.doi.org/10.7180/kmj.2015.30.2.109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Liu, Yi-Xun. "Apoptosis in ovary." Frontiers in Bioscience S3, no. 2 (2011): 680–97. http://dx.doi.org/10.2741/s180.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Patel, Swarup S., and Vincent Bamigboye. "Polycystic ovary syndrome." Morecambe Bay Medical Journal 4, no. 12 (September 1, 2005): 332–37. http://dx.doi.org/10.48037/mbmj.v4i12.901.

Full text
Abstract:
The term polycystic ovary syndrome (PCOS) is a misnomer as it gives an impression of an ovarian disease with cysts. It is, however, a multisystem disorder with very distressing signs and symptoms and long term consequences on the well being of the patient. Ms Patel and Mr Bamigboye, respectively specialist registrar and consultant in obstetrics and gynaecology, describe this common and complicated condition and its modern management.
APA, Harvard, Vancouver, ISO, and other styles
36

Franks, Stephen. "Polycystic ovary syndrome." Medicine 49, no. 9 (September 2021): 529–32. http://dx.doi.org/10.1016/j.mpmed.2021.06.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Monget, Philippe, Ken McNatty, and Danielle Monniaux. "The Crazy Ovary." Genes 12, no. 6 (June 18, 2021): 928. http://dx.doi.org/10.3390/genes12060928.

Full text
Abstract:
From fetal life until senescence, the ovary is an extremely active tissue undergoing continuous structural and functional changes. These ever-changing events are best summarized by a quotation attributed to Plato when describing motion in space and time—‘nothing ever is but is always becoming…’. With respect to the ovary, these changes include, at the beginning, the processes of follicular formation and thereafter those of follicular growth and atresia, steroidogenesis, oocyte maturation, and decisions relating to the number of mature oocytes that are ovulated for fertilization and the role of the corpus luteum. The aims of this review are to offer some examples of these complex and hitherto processes. The ones herein have been elucidated from studies undertaken in vitro or from normal in vivo events, natural genetic mutations or after experimental inactivation of gene function. Specifically, this review offers insights concerning the initiation of follicular growth, pathologies relating to poly-ovular follicles, the consequences of premature loss of germ cells or oocytes loss, the roles of AMH (anti-Müllerian hormone) and BMP (bone morphogenetic protein) genes in regulating follicular growth and ovulation rate together with species differences in maintaining luteal function during pregnancy. Collectively, the evidence suggests that the oocyte is a key organizer of normal ovarian function. It has been shown to influence the phenotype of the adjacent somatic cells, the growth and maturation of the follicle, and to determine the ovulation rate. When germ cells or oocytes are lost prematurely, the ovary becomes disorganized and a wide range of pathologies may arise.
APA, Harvard, Vancouver, ISO, and other styles
38

Mousa, Aya, Anju Joham, and Jacqueline Boyle. "Polycystic Ovary Syndrome." Seminars in Reproductive Medicine 39, no. 03/04 (July 2021): 069–70. http://dx.doi.org/10.1055/s-0041-1735506.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Baculescu, Nicoleta. "Polycystic Ovary Sindrome." Acta Endocrinologica (Bucharest) 4, no. 3 (2008): 362. http://dx.doi.org/10.4183/aeb.2008.362.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Ehrmann, David A. "Polycystic Ovary Syndrome." New England Journal of Medicine 352, no. 12 (March 24, 2005): 1223–36. http://dx.doi.org/10.1056/nejmra041536.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Balen, Adam. "Polycystic ovary syndrome." InnovAiT: Education and inspiration for general practice 9, no. 3 (March 2016): 144–50. http://dx.doi.org/10.1177/1755738015623299.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Homburg, R., L. C. Giudice, and R. J. Chang. "Polycystic ovary syndrome." Human Reproduction 11, no. 3 (March 1, 1996): 465–66. http://dx.doi.org/10.1093/humrep/11.3.465.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Cheung, Anthony P., and R. Jeffrey Chang. "Polycystic Ovary Syndrome." Clinical Obstetrics and Gynecology 33, no. 3 (September 1990): 655–67. http://dx.doi.org/10.1097/00003081-199009000-00029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Hamby, Barbara. "The Ovary Tattoo." Iowa Review 24, no. 1 (January 1994): 98–99. http://dx.doi.org/10.17077/0021-065x.4696.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Soulez, Benoit, Didier Dewailly, and Robert L. Rosenfield. "Polycystic Ovary Syndrome." Endocrinologist 6, no. 1 (January 1996): 19–29. http://dx.doi.org/10.1097/00019616-199601000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Macklon, N. S. "Polycystic ovary syndrome." BMJ 343, oct13 1 (October 13, 2011): d6407. http://dx.doi.org/10.1136/bmj.d6407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Walid, M. Sami, and Richard L. Heaton. "Doubled Left Ovary." Southern Medical Journal 102, no. 6 (June 2009): 671–72. http://dx.doi.org/10.1097/smj.0b013e3181a55da9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

McCartney, Christopher R., and John C. Marshall. "Polycystic Ovary Syndrome." New England Journal of Medicine 375, no. 1 (July 7, 2016): 54–64. http://dx.doi.org/10.1056/nejmcp1514916.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Franks, S. "Polycystic ovary syndrome." Archives of Disease in Childhood 77, no. 1 (July 1, 1997): 89–90. http://dx.doi.org/10.1136/adc.77.1.89.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Bergsjø, Per. "Polycystic Ovary Syndrome." Acta Obstetricia et Gynecologica Scandinavica 80, no. 7 (January 2001): 674. http://dx.doi.org/10.1080/j.1600-0412.2001.800721.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography